Exact Science | Washington State Medical Oncology Society (WSMOS) Conference

Home
Corporate Members
About
Previous Conferences
Agenda
Contact

Home
About us
Our services
Our clients
Contact

conference header

Visit Website

Request Info

Company Overview

Downloadable Resources

Oncotype MAPt Pan-Cancer Tissue Test Overview
RxPONDER - Oncotype DX Breast Cancer Assay N+
Oncotype DX Node Positive Sample Report

Contact

Connie Porta

cporta@exactsciences.com

Please don’t hesitate to contact us.

© 2021 WSMOS Conference. All Rights Reserved. Disclaimers

I Would Like Someone to Get in Touch With Me

First Name*
Last Name*
Institution*
Email*
Phone
Questions or Comments

Company Overview

Exact Sciences has added a new test to the Oncotype family. The Oncotype MAPTM Pan-Cancer Tissue test provides rapid, comprehensive genomic profiling to aid therapy selection for advanced cancer patients, with results in 3-5 business days following sample receipt. I’d love to share information about this exciting technology with your office. Please add me to your approved vendor list.

Company Overview

Epizyme, Inc. is a fully integrated biopharmaceutical company committed to rewriting treatment for cancer and other serious diseases through transformative epigenetic medicines. In addition to a robust research and discovery pipeline, Epizyme has one commercial oncology product and is exploring the treatment potential of this therapy in investigational clinical trials focused on other conditions. By focusing on the genetic drivers of disease, Epizyme works to match new medicines with the patients who need them. For more information, visit www.epizyme.com.

Company Overview

BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. Our employees around the world are committed to expediting the development of a diverse pipeline of novel therapeutics for cancer. We currently market an internally discovered product in the United States, BRUKINSA® (zanubrutinib).

I Would Like Someone to Get in Touch With Me

First Name*
Last Name*
Institution*
Email*
Phone
Questions or Comments

This browser is no longer recommended for use by Microsoft. To optimize your security and experience on WSMOSCONFERENCE website, we suggest using Google Chrome, Firefox or Microsoft Edge.

Company Overview

Kyowa Kirin is a global specialty pharmaceutical company with US Headquarters based in Bedminster, NJ. The company is focused primarily on developing and commercializing biopharmaceuticals that help improve the health and well-being of people through innovative and state-of-the-art technologies in various therapeutic areas including oncology, neurology, nephrology, and immunology. For additional information, you can visit us at www.kyowakirin.com.

I Would Like Someone to Get in Touch With Me

First Name*
Last Name*
Institution*
Email*
Phone
Questions or Comments

I Would Like Someone to Get in Touch With Me

First Name*
Last Name*
Institution*
Email*
Phone
Questions or Comments

Company Overview

EUSA Pharma is a dynamic, global biopharmaceutical company focused on oncology and rare disease, continuously striving to confront gaps in patient care. Our ambition drives us to deliver medical treatments that deliver real change to improve lives wherever they are needed in the world. As a young, specialty pharmaceutical company, EUSA Pharma is committed to delivering solutions that can have a meaningful effect on life, helping patients across a range of therapy areas.

I Would Like Someone to Get in Touch With Me

First Name*
Last Name*
Institution*
Email*
Phone
Questions or Comments

I Would Like Someone to Get in Touch With Me

First Name*
Last Name*
Institution*
Email*
Phone
Questions or Comments